Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCB101 in advanced colorectal cancer
NCT07204574Phase 2Recruiting
- Sponsor
- Chang Gung Memorial Hospital
- Start
- May 2025
- Primary completion
- Dec 2025
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of HCB-101 in colorectal cancer (CRC), sponsored by Chang Gung Memorial Hospital. Started May 2025; status: recruiting.
02
Drugs
HCB-101
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07204574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07204574.